Krane, Vera <br/><br/>
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.  [electronic resource] 

 -  Clinical journal of the American Society of Nephrology : CJASN  May 2010 
 - 874-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1555-905X 
<br/><br/><label>Standard No.: </label>10.2215/CJN.01170209  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies--blood<br/>Aspirin--adverse effects<br/>Atorvastatin<br/>Cause of Death<br/>Chi-Square Distribution<br/>Death, Sudden--etiology<br/>Diabetes Mellitus, Type 2--complications<br/>Double-Blind Method<br/>Female<br/>Germany<br/>Heparin--immunology<br/>Heptanoic Acids--therapeutic use<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Kaplan-Meier Estimate<br/>Kidney Diseases--complications<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--immunology<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Platelet Factor 4--immunology<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Pyrroles--therapeutic use<br/>Renal Dialysis--adverse effects<br/>Risk Assessment<br/>Risk Factors<br/>Stroke--immunology<br/>Time Factors<br/>Treatment Outcome